Intravascular delivery of non-viral nucleic acid
AssigneeMirus Bio Corporation
InventorsSean D. Monahan, Jon A. Wolff, Paul M. Slattum, James E. Hagstrom, Vladimir G. Budker, David B. Rozema
Life of this patent
Estimating the term…
Loading patent…
AssigneeMirus Bio Corporation
InventorsSean D. Monahan, Jon A. Wolff, Paul M. Slattum, James E. Hagstrom, Vladimir G. Budker, David B. Rozema
Estimating the term…
Disclosed is a process for transfecting genetic material into a mammalian cell to alter endogenous properties of the cell. The process comprises designing a polynucleotide for transfection. Then the polynucleotide is inserted into a mammalian vessel such as a tail vein or artery. Prior to insertion, subsequent to insertion, or concurrent with insertion the permeability of the vessel is increased thereby the genetic material is delivered to the parenchymal cell altering endogenous properties of the cell.
1) A process for delivering a polynucleotide complexed with a compound into a parenchymal cell of a mammal, comprising:
9) A process for transfecting genetic material into a mammalian cell, comprising:
Dependencies are inferred from the claim text.